(Q42940014)

11 November 2017

Effective treatment of mania with olanzapine: 2 case reports (English)

1 reference

11 November 2017

A V Ravindran

1

1 reference

11 November 2017

B W Jones

series ordinal

2

1 reference

11 November 2017

K al-Zaid

series ordinal

3

1 reference

11 November 2017

Y D Lapierre

series ordinal

4

1 reference

11 November 2017

1 November 1997

1 reference

Journal of Psychiatry & Neuroscience

11 November 2017

1 reference

11 November 2017

22

1 reference

11 November 2017

5

1 reference

11 November 2017

345-346

1 reference

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

11 November 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188885

First clinical experience with olanzapine (LY 170053): results of an open-label safety and dose-ranging study in patients with schizophrenia.

27 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1188885

Carbamazepine compared to haloperidol in acute mania

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9401315

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9401315

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9401315

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

11 November 2017

PubMed publication ID

9401315

1 reference